INTERNATIONAL PATENT: STROMACARE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CENTRE LEON BERARD, UNIVERSITE CLAUDE BERNARD LYON 1 FILES APPLICATION FOR "COMBINATION OF A ΒIG-H3 ANTAGONIST AND A PDFG-AA ANTAGONIST FOR THE TREATMENT OF CANCER"

GENEVA, April 6 -- STROMACARE (60 Avenue Rockefeller Immeuble Laennec69008 LYON), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, Rue de Tolbiac75013 PARIS), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, rue Michel Ange75016 PARIS), CENTRE LEON BERARD (28, rue Laennec69008 LYON), UNIVERSITE CLAUDE BERNARD LYON 1 (43, boulevard du 11 novembre 191869100 VILLEURBANNE) filed a patent application (PCT/EP2024/076742) for "COMBINATION OF A BetaIG-H3 ANTAGONIST AND A PDFG-AA ANTAGONIST FOR THE TREATMENT OF CANCER" on Sep 24, 2024. With publication no. WO/2025/068157, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classifica...